← Evidence map

ArticleAntimicrobial agents and chemotherapy2021

Clinical Impact of the Revised 2019 CLSI Levofloxacin Breakpoints in Patients with

Ho-Yin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33782006